Last reviewed · How we verify

NCT04491058

Assessment of Subsynovial Connective Tissue Thickness in Carpal Tunnel Syndrome

Completed Last updated 21 February 2025
What this trial tests

trial testing SSCT thickness measurement in Carpal Tunnel Syndrome in 92 participants. Completed in 6 May 2024.

Timeline
11 August 2020
Primary endpoint
6 May 2024
6 May 2024

Quick facts

Lead sponsorKU Leuven
StatusCompleted
Study typeOBSERVATIONAL
Enrollment92
Start date11 August 2020
Primary completion6 May 2024
Estimated completion6 May 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

KU Leuven — full company profile →

Who can join

18 and older, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The general aim of this research is to gain insight in the role of SSCT in the etiology and progression of CTS. We hypothesize that (degenerative) damage of the SSCT occurs early on in the pathogenesis of CTS. Fibrotic damage to the SSCT will lead to altered morphology and biomechanical characteristics. This eventually may lead to damage of the median nerve. To examine the SSCT an ultrasound technique described by Van Doesburg et al. 2012 will be used First, the reliability of the US technique to characterize morphology of the SSCT will be investigated. Secondly, cross-sectional data will be collected in healthy subjects and CTS patients to provide descriptive parameters and to describe differences between patients and controls. In the final part a prospective study will be conducted to look at changes of SSCT thickness over time and after treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04491058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing